(-)-epigallocatechin 3-gallate decreases expression EXP 6480464 epigallocatechin gallate results in decreased expression of SLC10A2 mRNA CTD PMID:23146761 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Ethinyl Estradiol results in decreased expression of SLC10A2 mRNA] CTD PMID:23146761 (1->4)-beta-D-glucan multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC10A2 mRNA CTD PMID:36331819 1,1-dichloroethene decreases expression ISO Slc10a2 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of SLC10A2 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO Slc10a2 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of SLC10A2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO Slc10a2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SLC10A2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Slc10a2 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of SLC10A2 mRNA] CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Ethinyl Estradiol results in decreased expression of SLC10A2 mRNA] CTD PMID:23146761 17alpha-ethynylestradiol multiple interactions ISO Slc10a2 (Mus musculus) 6480464 Metformin inhibits the reaction [Ethinyl Estradiol results in decreased expression of SLC10A2 protein] CTD PMID:34058177 17alpha-ethynylestradiol decreases expression ISO Slc10a2 (Mus musculus) 6480464 Ethinyl Estradiol results in decreased expression of SLC10A2 protein CTD PMID:34058177 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of SLC10A2 mRNA CTD PMID:23146761 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc10a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC10A2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc10a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC10A2 mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC10A2 mRNA CTD PMID:25975270 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO Slc10a2 (Mus musculus) 6480464 2 more ... CTD PMID:25768209 2-palmitoylglycerol increases expression ISO SLC10A2 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of SLC10A2 mRNA CTD PMID:37199045 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of SLC10A2 mRNA CTD PMID:28299817 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of SLC10A2 mRNA CTD PMID:28522335 acetamide increases expression EXP 6480464 acetamide results in increased expression of SLC10A2 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO Slc10a2 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of SLC10A2 mRNA CTD PMID:19770486 alfacalcidol increases expression ISO Slc10a2 (Mus musculus) 6480464 alfacalcidol results in increased expression of SLC10A2 mRNA CTD PMID:19581390 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC10A2 mRNA CTD PMID:16483693 atorvastatin calcium increases expression ISO Slc10a2 (Mus musculus) 6480464 Atorvastatin results in increased expression of SLC10A2 mRNA and Atorvastatin results in increased expression of SLC10A2 protein CTD PMID:15986414 aztreonam decreases expression ISO Slc10a2 (Mus musculus) 6480464 Aztreonam results in decreased expression of SLC10A2 mRNA CTD PMID:24657338 benzo[a]pyrene increases expression ISO SLC10A2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of SLC10A2 mRNA CTD PMID:22316170 benzo[a]pyrene affects methylation ISO SLC10A2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC10A2 exon and Benzo(a)pyrene affects the methylation of SLC10A2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO Slc10a2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SLC10A2 mRNA CTD PMID:19770486 and PMID:21964900 benzo[b]fluoranthene increases expression ISO Slc10a2 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of SLC10A2 mRNA CTD PMID:26377693 beta-hexachlorocyclohexane decreases expression ISO Slc10a2 (Mus musculus) 6480464 beta-hexachlorocyclohexane results in decreased expression of SLC10A2 mRNA CTD PMID:28392238 bis(2-ethylhexyl) phthalate decreases expression ISO Slc10a2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of SLC10A2 mRNA CTD PMID:28085963 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC10A2 mRNA CTD PMID:25181051 bisphenol A increases expression ISO Slc10a2 (Mus musculus) 6480464 bisphenol A results in increased expression of SLC10A2 mRNA CTD PMID:33221593 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of SLC10A2 mRNA CTD PMID:32479839 calcitriol increases expression ISO SLC10A2 (Homo sapiens) 6480464 Calcitriol results in increased expression of SLC10A2 mRNA CTD PMID:16002434 carbon nanotube increases expression ISO Slc10a2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 chenodeoxycholic acid multiple interactions ISO SLC10A2 (Homo sapiens) 6480464 Chenodeoxycholic Acid inhibits the reaction [SLC10A2 protein results in increased transport of Taurocholic Acid] CTD PMID:25466967 cholic acid decreases expression ISO Slc10a2 (Mus musculus) 6480464 Cholic Acid results in decreased expression of SLC10A2 mRNA CTD PMID:25582706 cholic acid affects expression EXP 6480464 Cholic Acid affects the expression of SLC10A2 mRNA CTD PMID:35584729 cholic acid decreases expression EXP 6480464 Cholic Acid results in decreased expression of SLC10A2 protein CTD PMID:35584729 choline multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC10A2 mRNA CTD PMID:20938992 ciguatoxin CTX1B affects expression ISO Slc10a2 (Mus musculus) 6480464 Ciguatoxins affects the expression of SLC10A2 mRNA CTD PMID:18353800 clofibrate decreases expression ISO Slc10a2 (Mus musculus) 6480464 Clofibrate results in decreased expression of SLC10A2 mRNA CTD PMID:25270620 and PMID:28973556 clofibrate multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [PPARA gene mutant form results in increased susceptibility to Clofibrate] which results in increased expression of SLC10A2 mRNA CTD PMID:29175453 cyclosporin A decreases expression ISO Slc10a2 (Mus musculus) 6480464 Cyclosporine results in decreased expression of SLC10A2 mRNA CTD PMID:19770486 DDE decreases expression ISO Slc10a2 (Mus musculus) 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC10A2 mRNA CTD PMID:28392238 deoxynivalenol multiple interactions ISO SLC10A2 (Homo sapiens) 6480464 GW 4064 inhibits the reaction [deoxynivalenol results in decreased expression of SLC10A2 mRNA] and SB 203580 inhibits the reaction [deoxynivalenol results in decreased expression of SLC10A2 mRNA] CTD PMID:35224661 and PMID:37315771 deoxynivalenol decreases expression ISO SLC10A2 (Homo sapiens) 6480464 deoxynivalenol results in decreased expression of SLC10A2 mRNA CTD PMID:35224661 and PMID:37315771 dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of SLC10A2 mRNA CTD PMID:15102944 dexamethasone increases expression ISO Slc10a2 (Mus musculus) 6480464 Dexamethasone results in increased expression of SLC10A2 mRNA CTD PMID:29222744 dexamethasone multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [Dexamethasone co-treated with Ibuprofen] results in increased expression of SLC10A2 mRNA CTD PMID:29222744 dextran sulfate multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC10A2 mRNA CTD PMID:29950665 dibenz[a,h]anthracene increases expression ISO Slc10a2 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 dichloroacetic acid decreases expression ISO Slc10a2 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of SLC10A2 mRNA CTD PMID:28962523 diclofenac increases expression ISO Slc10a2 (Mus musculus) 6480464 Diclofenac results in increased expression of SLC10A2 mRNA CTD PMID:26934552 diquat increases expression ISO Slc10a2 (Mus musculus) 6480464 Diquat results in increased expression of SLC10A2 protein CTD PMID:36851058 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SLC10A2 mRNA CTD PMID:29391264 enilconazole increases expression ISO Slc10a2 (Mus musculus) 6480464 enilconazole results in increased expression of SLC10A2 mRNA CTD PMID:32814239 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of SLC10A2 mRNA CTD PMID:15353170 ethanol decreases expression ISO Slc10a2 (Mus musculus) 6480464 Ethanol results in decreased expression of SLC10A2 mRNA CTD PMID:19167417 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC10A2 mRNA CTD PMID:24793618 folic acid multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC10A2 mRNA more ... CTD PMID:20938992 and PMID:22206623 furan increases expression ISO Slc10a2 (Mus musculus) 6480464 furan results in increased expression of SLC10A2 mRNA CTD PMID:24183702 genistein decreases expression ISO Slc10a2 (Mus musculus) 6480464 Genistein results in decreased expression of SLC10A2 mRNA CTD PMID:24967385 graphite affects expression EXP 6480464 Graphite affects the expression of SLC10A2 mRNA CTD PMID:29933104 GW 4064 multiple interactions ISO SLC10A2 (Homo sapiens) 6480464 GW 4064 inhibits the reaction [deoxynivalenol results in decreased expression of SLC10A2 mRNA] CTD PMID:35224661 ibuprofen multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [Dexamethasone co-treated with Ibuprofen] results in increased expression of SLC10A2 mRNA CTD PMID:29222744 indocyanine green increases uptake ISO SLC10A2 (Homo sapiens) 6480464 SLC10A2 protein results in increased uptake of Indocyanine Green CTD PMID:32209977 inulin multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC10A2 mRNA CTD PMID:36331819 L-methionine multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SLC10A2 mRNA CTD PMID:20938992 lactacystin multiple interactions ISO SLC10A2 (Homo sapiens) 6480464 lactacystin inhibits the reaction [resveratrol results in decreased expression of SLC10A2 protein] CTD PMID:24498857 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of SLC10A2 mRNA CTD PMID:24136188 lithocholic acid multiple interactions ISO Slc10a2 (Mus musculus) 6480464 NR1H3 protein inhibits the reaction [Lithocholic Acid results in increased expression of SLC10A2 mRNA] CTD PMID:17256725 lithocholic acid increases expression ISO Slc10a2 (Mus musculus) 6480464 Lithocholic Acid results in increased expression of SLC10A2 mRNA CTD PMID:17256725 and PMID:25582706 metformin multiple interactions ISO Slc10a2 (Mus musculus) 6480464 Metformin inhibits the reaction [Ethinyl Estradiol results in decreased expression of SLC10A2 protein] CTD PMID:34058177 metformin increases expression ISO Slc10a2 (Mus musculus) 6480464 Metformin results in increased expression of SLC10A2 protein CTD PMID:34058177 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of SLC10A2 mRNA CTD PMID:21515302 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO Slc10a2 (Mus musculus) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SLC10A2 protein CTD PMID:23872411 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO SLC10A2 (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [resveratrol results in decreased expression of SLC10A2 protein] CTD PMID:24498857 N-nitrosodiethylamine multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SLC10A2 mRNA CTD PMID:24535843 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of SLC10A2 mRNA CTD PMID:23439660 paracetamol affects expression ISO Slc10a2 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC10A2 mRNA CTD PMID:17562736 paracetamol increases expression ISO Slc10a2 (Mus musculus) 6480464 Acetaminophen results in increased expression of SLC10A2 mRNA CTD PMID:29246445 paracetamol multiple interactions ISO Slc10a2 (Mus musculus) 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of SLC10A2 mRNA] CTD PMID:29246445 perfluorohexanesulfonic acid decreases expression ISO Slc10a2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of SLC10A2 mRNA CTD PMID:21705711 perfluorononanoic acid multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [Dietary Fats co-treated with perfluoro-n-nonanoic acid] results in decreased expression of SLC10A2 mRNA CTD PMID:33483757 perfluorooctane-1-sulfonic acid decreases expression ISO Slc10a2 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC10A2 mRNA CTD PMID:21705711 perfluorooctane-1-sulfonic acid multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC10A2 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC10A2 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid increases transport ISO SLC10A2 (Homo sapiens) 6480464 SLC10A2 protein results in increased transport of perfluorooctane sulfonic acid CTD PMID:26001962 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of SLC10A2 mRNA CTD PMID:28511854 perfluorooctanoic acid affects methylation ISO SLC10A2 (Homo sapiens) 6480464 perfluorooctanoic acid affects the methylation of SLC10A2 gene CTD PMID:35266797 perfluorooctanoic acid decreases expression ISO Slc10a2 (Mus musculus) 6480464 perfluorooctanoic acid results in decreased expression of SLC10A2 mRNA CTD PMID:30657992 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of SLC10A2 mRNA CTD PMID:31324951 phenobarbital increases expression ISO Slc10a2 (Mus musculus) 6480464 Phenobarbital results in increased expression of SLC10A2 mRNA CTD PMID:19482888 phenobarbital affects expression ISO Slc10a2 (Mus musculus) 6480464 Phenobarbital affects the expression of SLC10A2 mRNA CTD PMID:23091169 phenobarbital multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SLC10A2 mRNA and NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SLC10A2 mRNA] CTD PMID:19482888 and PMID:24535843 pirinixic acid multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC10A2 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO Slc10a2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of SLC10A2 mRNA CTD PMID:25270620 pregnenolone 16alpha-carbonitrile increases expression ISO Slc10a2 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of SLC10A2 mRNA CTD PMID:28903501 procymidone increases expression ISO Slc10a2 (Mus musculus) 6480464 procymidone results in increased expression of SLC10A2 mRNA CTD PMID:36764477 propiconazole increases expression ISO Slc10a2 (Mus musculus) 6480464 propiconazole results in increased expression of SLC10A2 mRNA CTD PMID:21278054 Prothioconazole-desthio decreases expression ISO Slc10a2 (Mus musculus) 6480464 prothioconazole-desthio results in decreased expression of SLC10A2 mRNA CTD PMID:36007749 resveratrol multiple interactions ISO SLC10A2 (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [resveratrol results in decreased expression of SLC10A2 protein] more ... CTD PMID:24498857 resveratrol multiple interactions EXP 6480464 resveratrol results in decreased expression of and results in decreased activity of SLC10A2 protein and resveratrol results in decreased expression of and results in decreased activity of SLC10A2 protein mutant form CTD PMID:24498857 resveratrol decreases expression ISO SLC10A2 (Homo sapiens) 6480464 resveratrol results in decreased expression of SLC10A2 mRNA CTD PMID:24498857 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SLC10A2 mRNA CTD PMID:28374803 SB 203580 multiple interactions ISO SLC10A2 (Homo sapiens) 6480464 SB 203580 inhibits the reaction [deoxynivalenol results in decreased expression of SLC10A2 mRNA] CTD PMID:37315771 streptozocin multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of SLC10A2 mRNA CTD PMID:29382564 tauro-beta-muricholic acid increases expression EXP 6480464 tauromuricholic acid results in increased expression of SLC10A2 protein CTD PMID:11672435 taurochenodeoxycholic acid increases expression EXP 6480464 Taurochenodeoxycholic Acid results in increased expression of SLC10A2 protein CTD PMID:11672435 taurocholic acid increases uptake EXP 6480464 SLC10A2 protein results in increased uptake of Taurocholic Acid CTD PMID:19464309 taurocholic acid increases transport ISO SLC10A2 (Homo sapiens) 6480464 SLC10A2 protein results in increased transport of Taurocholic Acid CTD PMID:25466967 taurocholic acid multiple interactions ISO SLC10A2 (Homo sapiens) 6480464 Chenodeoxycholic Acid inhibits the reaction [SLC10A2 protein results in increased transport of Taurocholic Acid] CTD PMID:25466967 taurocholic acid multiple interactions EXP 6480464 Bile Acids and Salts inhibits the reaction [SLC10A2 protein results in increased uptake of Taurocholic Acid] CTD PMID:19464309 tauroursodeoxycholic acid increases expression EXP 6480464 ursodoxicoltaurine results in increased expression of SLC10A2 protein CTD PMID:11672435 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of SLC10A2 mRNA CTD PMID:21515302 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC10A2 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO Slc10a2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of SLC10A2 mRNA CTD PMID:31919559 tetracycline decreases expression ISO Slc10a2 (Mus musculus) 6480464 Tetracycline results in decreased expression of SLC10A2 mRNA CTD PMID:24489787 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC10A2 mRNA CTD PMID:26222700 and PMID:34492290 titanium dioxide multiple interactions ISO Slc10a2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC10A2 mRNA CTD PMID:29950665 toluene affects expression EXP 6480464 Toluene affects the expression of SLC10A2 mRNA CTD PMID:18653662 triphenyl phosphate decreases expression ISO Slc10a2 (Mus musculus) 6480464 triphenyl phosphate results in decreased expression of SLC10A2 mRNA CTD PMID:36563926 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of SLC10A2 mRNA CTD PMID:21515302 troglitazone increases expression ISO Slc10a2 (Mus musculus) 6480464 troglitazone results in increased expression of SLC10A2 mRNA CTD PMID:28973697 ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of SLC10A2 mRNA CTD PMID:16764892 ursodeoxycholic acid increases expression ISO Slc10a2 (Mus musculus) 6480464 Ursodeoxycholic Acid results in increased expression of SLC10A2 mRNA CTD PMID:25582706 vincristine increases response to substance ISO SLC10A2 (Homo sapiens) 6480464 SLC10A2 gene SNP results in increased susceptibility to Vincristine CTD PMID:21245421